| 54 |
Titel |
TI |
[DE] TROCKENPULVERZUSAMMENSETZUNG MIT LANGKETTIGER RNA
[EN] DRY POWDER COMPOSITION COMPRISING LONG-CHAIN RNA
[FR] COMPOSITION DE POUDRE SÈCHE COMPRENANT DE L'ARN À LONGUE CHAÎNE |
| 71/73 |
Anmelder/Inhaber |
PA |
CUREVAC AG, DE
|
| 72 |
Erfinder |
IN |
EBER FABIAN JOHANNES, DE
;
KETTERER THOMAS, DE
;
KOLLAND KATHARINA, DE
;
MUTZKE THORSTEN, DE
;
ROOS TILMANN, DE
;
SEWIG STEFANIE, DE
;
SONNTAG MICHAEL, DE
;
WIGGENHORN MICHAEL, DE
;
YAZDAN PANAH BENYAMIN, DE
|
| 22/96 |
Anmeldedatum |
AD |
20.05.2016 |
| 21 |
Anmeldenummer |
AN |
21172283 |
|
Anmeldeland |
AC |
EP |
|
Veröffentlichungsdatum |
PUB |
01.12.2021 |
33
31
32 |
Priorität |
PRC
PRN
PRD |
EP
2015002019
13.10.2015
|
33
31
32 |
PRC
PRN
PRD |
EP
2016000842
20.05.2016
|
33
31
32 |
PRC
PRN
PRD |
EP
15001517
20.05.2015
|
33
31
32 |
PRC
PRN
PRD |
EP
16725366
20.05.2016
|
| 51 |
IPC-Hauptklasse |
ICM |
C12N 15/10
(2006.01)
|
| 51 |
IPC-Nebenklasse |
ICS |
A61K 48/00
(2006.01)
|
|
IPC-Zusatzklasse |
ICA |
|
|
IPC-Indexklasse |
ICI |
|
|
Gemeinsame Patentklassifikation |
CPC |
A61K 2039/53
A61K 39/145
A61K 48/00
A61K 48/005
A61K 48/0091
A61K 9/16
A61K 9/1682
A61P 31/00
A61P 31/04
A61P 31/12
A61P 33/02
A61P 35/00
A61P 37/06
A61P 37/08
|
|
MCD-Hauptklasse |
MCM |
C12N 15/10
(2006.01)
|
|
MCD-Nebenklasse |
MCS |
A61K 48/00
(2006.01)
|
|
MCD-Zusatzklasse |
MCA |
|
| 57 |
Zusammenfassung |
AB |
[EN] The present invention is directed to a storage-stable formulation of long-chain RNA. In particular, the invention concerns a dry powder composition comprising a long-chain RNA molecule. The present invention is furthermore directed to methods for preparing a dry powder composition comprising a long-chain RNA molecule by spray-drying. The invention further concerns the use of such a dry powder composition comprising a long-chain RNA molecule in the preparation of pharmaceutical compositions and vaccines, to a method of treating or preventing a disorder or a disease, to first and second medical uses of such a dry powder composition comprising a long-chain RNA molecule and to kits, particularly to kits of parts, comprising such a dry powder composition comprising a long-chain RNA molecule. |
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt |
CT |
|
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt |
CT |
NL000006022009A
US020110077284A1
WO002008077592A1
WO002009095226A2
WO002010037539A1
WO002011026641A1
WO002011069586A1
WO002011069587A1
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt |
CTNP |
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt |
CTNP |
ADV DRUG DELIV REV, vol. 66, February 2014 (2014-02-01), pages 110 - 116 1;
AKASHI, CURR. OPIN. GENET. DEV., vol. 11, no. 6, 2001, pages 660 - 666 1;
FRONT PHARMACOL, vol. 6, 1 December 2015 (2015-12-01), pages 286 1;
INT J NANOMEDICINE, vol. 9, 2014, pages 1833 - 1843 1;
POXON ET AL., PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, vol. 5, no. 1, 2000, pages 115 - 122 1
|
|
Zitierende Dokumente |
|
Dokumente ermitteln
|
|
Sequenzprotokoll |
|
|
|
Prüfstoff-IPC |
ICP |
A61K 48/00
A61K 9/16
A61P 31/00
A61P 31/04
A61P 31/12
A61P 33/02
A61P 35/00
A61P 37/06
A61P 37/08
C12N 15/10
|
